This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2019 Nov 26;322(20):2017-2018.

doi: 10.1001/jama.2019.15781.

Bisphosphonates for Postmenopausal Osteoporosis

Kristine E Ensrud^{1

2}, Carolyn J Crandall^{3

4}

Affiliations

Affiliations

¹ Division of Epidemiology & Community Health, Department of Medicine, University of Minnesota, Minneapolis.
² Center for Care Delivery and Outcomes Research, Veterans Affairs Health Care System, Minneapolis, Minnesota.
³ Department of Medicine, University of California, Los Angeles.
⁴ Associate Editor, JAMA.

PMID: 31621799
DOI: 10.1001/jama.2019.15781

Bisphosphonates for Postmenopausal Osteoporosis

Kristine E Ensrud et al. JAMA. 2019.

. 2019 Nov 26;322(20):2017-2018.

doi: 10.1001/jama.2019.15781.

Authors

Kristine E Ensrud^{1

2}, Carolyn J Crandall^{3

4}

Affiliations

¹ Division of Epidemiology & Community Health, Department of Medicine, University of Minnesota, Minneapolis.
² Center for Care Delivery and Outcomes Research, Veterans Affairs Health Care System, Minneapolis, Minnesota.
³ Department of Medicine, University of California, Los Angeles.
⁴ Associate Editor, JAMA.

PMID: 31621799
DOI: 10.1001/jama.2019.15781

No abstract available

PubMed Disclaimer

Comment in

Bisphosphonates for Osteopenia in Postmenopausal Women.
Snyder S. Snyder S. JAMA. 2020 Mar 17;323(11):1096. doi: 10.1001/jama.2020.0602. JAMA. 2020. PMID: 32181842 No abstract available.

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems